Remote speech tests can complement in-clinic exams to help guide treatment for Multiple Sclerosis (MS). Previous studies suggested that speech patterns could indicate MS progression. In this study, speech from MS patients was recorded at different intervals over a year. Only those with a confirmed MS diagnosis and no other speech disorders were included. Most changes in speech over time were small and fell within normal short-term variations, regardless of disease progression. Familiarity with the tests might have reduced the ability to detect changes.

For this study, Redenlab collaborated with Monash University, The University of Melbourne and Bionics Institute.

The paper was written by Redenlab Medical Officer Gustavo Noffs, Thushara Perera, Helmut Butzkueven, Scott Kolbe, Frederique M.C. Boonstra, Adam Vogel and Anneke Van der Walt.

For more information, please click here.